Lincosamides

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

antibiotics produced by Streptomyces species. There is a relationship to the macrolide antibiotics with regard to spectrum of action and mechanism of action. The only representative of lincosamides is clindamycin, a semi-synthetic analogue of lincomycin. Clindamycin is a weak base that is attached to the 50S subunit of bacterial ribosomes and inhibits protein synthesis.

Remark: Lincomycin is no longer used by hete.

Pharmacodynamics (Effect)This section has been translated automatically.

Inhibition of protein synthesis at the 50S subunit of the bacterial ribosome.

Note(s)This section has been translated automatically.

Clindamycin is the most effective antibiotic against anaerobes. It is also excellent against staphylococci and good against streptococci and pneumococci.

LiteratureThis section has been translated automatically.

Graefe KH et al (2016) Antibacterial agents. In: Graefe KH et al (Eds) Pharmacology and Toxicology. Georg Thieme Publisher Stuttgart S. 583-584

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer